Lahore: Highnoon Laboratories Limited has scheduled a meeting of its Board of Directors on April 30, 2025, in Lahore. The primary agenda of this meeting is to consider and approve the un-audited financial accounts for the first quarter, which concluded on March 31, 2025.

In compliance with the Pakistan Stock Exchange (PSX) regulations, the company has declared a "Closed Period" from April 23 to April 30, 2025. During this time, no Director, CEO, or Executive of Highnoon Laboratories Limited is permitted to engage in any direct or indirect transactions involving the company’s shares.

According to information available from the Pakistan Stock Exchange (PSX), the closed period is instituted to maintain market integrity and prevent insider trading. This ensures that all stakeholders have equal access to the company's financial information once it is publicly released.

Highnoon Laboratories Limited operates within the designated market category of pharmaceuticals. The outcome of this board meeting, particularly the approval of the quarterly accounts, is anticipated by investors and stakeholders for insights into the company’s financial standing and operational performance during the first quarter of 2025.